The ratio between serum levels of insulin‐like growth factor (IGF)‐I and the IGF binding proteins (IGFBP‐1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients

OBJECTIVE Several in‐vitro studies have suggested that the biological actions of IGF‐I can be modified by the presence of specific IGF binding proteins. In man, the 24‐hour serum levels of IGF‐I and IGFBP‐3 remain constant, but short‐term changes in the IGF‐l/IGFBP‐3 ratio have been described following GH administration. Serum levels of IGF‐I and IGFBP‐3 decrease with age in normal adults and are elevated In active acromegaly due to excessive GH secretion. However, the Individual ratios between serum levels of IGF‐I and IGFBP‐3 in acromegalic and healthy adults have not been described previously.

[1]  N. Skakkebaek,et al.  Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. , 1994, The Journal of clinical endocrinology and metabolism.

[2]  M. Ranke,et al.  Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. , 1993, The Journal of clinical endocrinology and metabolism.

[3]  M. Ranke,et al.  Clinical studies of IGFBP-2 by radioimmunoassay. , 1993, Growth regulation.

[4]  M. Blackman,et al.  Serum IGF-binding protein-3 is related to IGF-I, but not to spontaneous GH release, in healthy old men. , 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[5]  S. Lamberts,et al.  The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex , 1992, Clinical endocrinology.

[6]  K. Hopkins,et al.  Insulin secretion and insulin‐like growth factor‐I levels in active and controlled acromegaly , 1992, Clinical endocrinology.

[7]  A. Herington,et al.  Tissue distribution and regulation of insulin-like growth factor (IGF)-binding protein-3 messenger ribonucleic acid (mRNA) in the rat: comparison with IGF-I mRNA expression. , 1992, Endocrinology.

[8]  J. Holly,et al.  Insulin-like growth factor binding proteins (IGFBPs) in acromegaly. , 1991, Growth regulation.

[9]  C. Conover,et al.  Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. , 1991, Endocrinology.

[10]  K. Hall,et al.  Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. , 1991, Acta endocrinologica.

[11]  M. Ranke,et al.  Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. , 1991, The Journal of clinical endocrinology and metabolism.

[12]  N. Skakkebaek,et al.  Urinary growth hormone excretion in 657 healthy children and adults: normal values, inter- and intraindividual variations. , 1991, Hormone research.

[13]  M. Ranke,et al.  Circadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormone-deficient patients and age- and sex-matched normal subjects. , 1990, Acta endocrinologica.

[14]  E. Rutanen,et al.  Insulin-like growth factors and their binding proteins. , 1990, Acta endocrinologica.

[15]  H. Zeisel,et al.  A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. , 1990, The Journal of clinical endocrinology and metabolism.

[16]  M. Ranke,et al.  Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. , 1989, Endocrinology.

[17]  R. Gopinath,et al.  Porcine Insulin-Like Growth Factor (IGF) Binding Protein Blocks IGF-I Action on Porcine Adipose Tissue 1 , 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[18]  R. Baxter,et al.  Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. , 1988, Biochemical and biophysical research communications.

[19]  K. Hall,et al.  Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. , 1988, Acta endocrinologica.

[20]  M. Ranke,et al.  A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. , 1988, Acta endocrinologica.

[21]  A. Giwercman,et al.  INVESTIGATION OF THE CRITERIA FOR ASSESSING THE OUTCOME OF TREATMENT IN ACROMEGALY , 1987, Clinical endocrinology.

[22]  W. Daughaday,et al.  Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH. , 1987, The Journal of clinical endocrinology and metabolism.

[23]  S. Lamberts,et al.  Relationship between growth hormone and Somatomedin‐C levels in untreated acromegaly, after surgery and radiotherapy and during medical therapy with Sandostatin (SMS 201–995) , 1987, European journal of clinical investigation.

[24]  R. Fenstermaker,et al.  Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. , 1987, The Journal of laboratory and clinical medicine.

[25]  A. Rogol,et al.  Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. , 1987, The Journal of clinical endocrinology and metabolism.

[26]  R. Baxter,et al.  Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. , 1986, The Journal of clinical investigation.

[27]  R. Baxter,et al.  Insulin-like growth factor-binding protein from human plasma. Purification and characterization. , 1986, The Journal of biological chemistry.

[28]  Y. Le Bouc,et al.  Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents. , 1984, The Journal of clinical endocrinology and metabolism.

[29]  M. Binoux,et al.  Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels. , 1984, The Journal of clinical endocrinology and metabolism.

[30]  K. Hall,et al.  Somatomedin levels in childhood, adolescence and adult life. , 1984, Clinics in endocrinology and metabolism.

[31]  E. Froesch,et al.  Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. , 1981, The Journal of clinical investigation.

[32]  D. Clemmons,et al.  Evaluation of acromegaly by radioimmunoassay of somatomedin-C. , 1979, The New England journal of medicine.

[33]  R. Furlanetto,et al.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. , 1977, The Journal of clinical investigation.